Table 2.
Weighted association of METS-IR with hypertension in different models among all participants
| Exposure | Model 1 | Model 2 | Model 3 |
|---|---|---|---|
| OR (95% CI), P-value | OR (95% CI), P-value | OR (95% CI), P-value | |
| Continuous | 1.50 (1.40–1.60), < 0.001 | 1.52 (1.41–1.63), < 0.001 | 1.46 (1.36–1.58), < 0.001 |
| METS-IR quartile | |||
| Q1 | Reference | Reference | Reference |
| Q2 | 1.86 (1.49–2.34), < 0.001 | 1.64 (1.28–2.11), < 0.001 | 1.61 (1.27–2.06), < 0.001 |
| Q3 | 2.30 (1.84–2.87), < 0.001 | 2.07 (1.63–2.64), < 0.001 | 2.01 (1.57–258), < 0.001 |
| Q4 | 3.67 (2.95–4.55), < 0.001 | 3.66 (2.91–4.60), < 0.001 | 3.31 (2.64–4.14), < 0.001 |
| P for trend | 1.03 (1.03–1.04), < 0.001 | 1.04 (1.03–1.04), < 0.001 | 1.03 (1.03–1.04), < 0.001 |
CI, confidence interval; METS-IR, Metabolic Score for Insulin Resistance; OR, odds ratio
Note: In the multivariate analysis, the visceral adiposity index was converted from a continuous for categorical variables (tertiles)
Model 1: no covariates adjusted
Model 2: adjusted for age, sex, and race
Model 3: adjusted for the covariates in Model 2 as well as education level, marital status, poverty-to-income ratio, serum creatinine, total cholesterol, low-density lipoprotein cholesterol, smoking, alcohol consumption, stroke, coronary heart disease, and diabetes